Adapting low-dose buprenorphine induction to meet patient needs: A pilot study

INTRODUCTION: Low-dose buprenorphine induction (LDBI) has been proposed to initiate buprenorphine in patients who are taking full opioid agonists in order to limit the risk of precipitated withdrawal. The objective of this study was to understand how real-world patient-specific adjustments in LDBI p...

Descripción completa

Detalles Bibliográficos
Autores principales: Karavolis, Zoe A., Roy, Payel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948859/
https://www.ncbi.nlm.nih.gov/pubmed/36844162
http://dx.doi.org/10.1016/j.dadr.2022.100104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948859/
https://www.ncbi.nlm.nih.gov/pubmed/36844162
http://dx.doi.org/10.1016/j.dadr.2022.100104

Ejemplares similares